Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus morphine added to epidural bupivacaine for leg fracture surgery
IRCT20180602039954N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine, morphine and bupivacaine in Leg fracture (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Time to reach sensory block to T12, Duration of sensory block and 3 more. Started Jan 2018; status: completed.
02
Drugs
dexmedetomidinemorphinebupivacaine
03
Conditions
Leg fracture
Beyond the preview
Go deeper on IRCT20180602039954N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180602039954N1.